Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
3
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
amarin
amgen
What
drug
3
×
patients
3
×
cancer
market
medicine
advantages
aid
bar
bio
brings
commercialize
discovery
drugs
eisai
expect
fda
flags
fred
fresh
funding
gamble
higher
hutch
incidence
looks
lorcaserin
loss
marketing
match
medco’s
million
mover
new
patient’s
payers
physicians
plan
platform
post
precision
Language
unset
Current search:
patients
×
cancer
×
drug
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@geekwire.com
4 years ago
Fred Hutch spinout SEngine raises $5.1M to test cancer treatment drugs against a patient’s tumors
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
